《中国女性乳腺癌筛查指南》解读(精简版)

乳腺癌是中国女性最常见的恶性肿瘤,早期筛查是提高乳腺癌早诊早治最佳途径。中国女性乳腺癌发病高峰年龄与欧美国家乳腺癌发病高峰年龄明显不同,制定适合中国女性特点的群体性乳腺癌筛查指南势在必行。中国抗癌协会与国家肿瘤临床医学研究中心(天津医科大学肿瘤医院)组织专家在分析总结中国女性乳腺癌筛查数据的基础上,参考欧美及东亚等国家的最新乳腺癌筛查指南或共识,分别从筛查起始年龄、筛查方法、筛查时间间隔3个方面,针对中国女性乳腺癌一般风险人群和高危风险人群制定以人群为基础的《中国女性乳腺癌筛查指南》,本文对该指南进行解读以供乳腺癌筛查相关人士参考。

Interpretation of guideline for breast cancer screening in Chinese women

Breast cancer is the most common cancer for Chinese women. Early screening is the best way to improve the rates of early diagnosis and early treatment of breast cancer. The peak ages of breast cancer in Chinese women are obviously different from those in the European and American countries. It is imperative to develop a guideline for breast cancer screening that is suitable for Chinese women. Based on the analysis and summary of breast cancer screening data in China, and the latest guidelines and consensus on breast cancer screening in Europe, the United States and East Asia, China Anti-Cancer Association and National Clinical Research Center for Cancer (Tianjin Medical University Cancer Institute and Hospital) has developed a population-based guideline for breast cancer screening in Chinese women. This guideline has provided detailed recommendations on the screening starting age, screening modalities, and screening interval in Chinese women with average risk and high risk of breast cancer, respectively. This article aims to interpret the above guideline, providing references for professionals in breast cancer screening.